Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Growing pressure on employer-sponsored plans, combined with mounting evidence of cardiovascular benefits, is slowly moving the needle
The MHRA approved the Wegovy pill (oral semaglutide 25 mg) in June 2026, and it reached private providers in July 2026
There might not be a one-size-fits-all approach to weight loss, but with personalized treatment plans through Hers, you can take control of your health and adopt a weight-loss strategy that's actually feasible for you
Direct-to-consumer via TrumpRx or the manufacturers: $350/month now, $250 in two years, with oral starters at $149
Lillys Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Delivered Superior Efficacy in First-of-Its-Kind Phase 3b Trial for Adults with Active Psoriatic Arthritis and Obesity or Overweight
This injection helps in improving nerve health, reducing numbness, and supporting overall body function
US$ 20.35
US$ 27.17
US$ 28.09
